Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy)

(1) Background: Postoperative vaginal-cuff HDR interventional radiotherapy (brachytherapy) is a standard treatment in early-stage endometrial cancer. This study reports the effect of in vivo dosimetry-based biological planning for two different fractionation schedules on the treatment-related toxici...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tamer Soror, Ramin Chafii, Valentina Lancellotta, Luca Tagliaferri, György Kovács
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/72b51afaad9743568ded63bddfb66880
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:72b51afaad9743568ded63bddfb66880
record_format dspace
spelling oai:doaj.org-article:72b51afaad9743568ded63bddfb668802021-11-25T16:49:47ZBiological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy)10.3390/biomedicines91116292227-9059https://doaj.org/article/72b51afaad9743568ded63bddfb668802021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9059/9/11/1629https://doaj.org/toc/2227-9059(1) Background: Postoperative vaginal-cuff HDR interventional radiotherapy (brachytherapy) is a standard treatment in early-stage endometrial cancer. This study reports the effect of in vivo dosimetry-based biological planning for two different fractionation schedules on the treatment-related toxicities. (2) Methods: 121 patients were treated. Group A (82) received 21 Gy in three fractions. Group B (39) received 20 Gy in four fractions. The dose was prescribed at a 5 mm depth or to the applicator surface according to the distance between the applicator and the rectum. In vivo dosimetry measured the dose of the rectum and/or urinary bladder. With a high measured dose, the dose prescription was changed from a 5 mm depth to the applicator surface. (3) Results: The median age was 66 years with 58.8 months mean follow-up. The dose prescription was changed in 20.7% of group A and in 41% of group B. Most toxicities were grade 1–2. Acute urinary toxicities were significantly higher in group A. The rates of acute and late urinary toxicities were significantly higher with a mean bladder dose/fraction of >2.5 Gy and a total bladder dose of >7.5 Gy. One patient had a vaginal recurrence. (4) Conclusions: Both schedules have excellent local control and acceptable rates of toxicities. Using in vivo dosimetry-based biological planning yielded an acceptable dose to the bladder and rectum.Tamer SororRamin ChafiiValentina LancellottaLuca TagliaferriGyörgy KovácsMDPI AGarticleinterventional radiotherapyvaginal-cuff brachytherapyHDR brachytherapyin vivo dosimetryendometrial cancerbiological planningBiology (General)QH301-705.5ENBiomedicines, Vol 9, Iss 1629, p 1629 (2021)
institution DOAJ
collection DOAJ
language EN
topic interventional radiotherapy
vaginal-cuff brachytherapy
HDR brachytherapy
in vivo dosimetry
endometrial cancer
biological planning
Biology (General)
QH301-705.5
spellingShingle interventional radiotherapy
vaginal-cuff brachytherapy
HDR brachytherapy
in vivo dosimetry
endometrial cancer
biological planning
Biology (General)
QH301-705.5
Tamer Soror
Ramin Chafii
Valentina Lancellotta
Luca Tagliaferri
György Kovács
Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy)
description (1) Background: Postoperative vaginal-cuff HDR interventional radiotherapy (brachytherapy) is a standard treatment in early-stage endometrial cancer. This study reports the effect of in vivo dosimetry-based biological planning for two different fractionation schedules on the treatment-related toxicities. (2) Methods: 121 patients were treated. Group A (82) received 21 Gy in three fractions. Group B (39) received 20 Gy in four fractions. The dose was prescribed at a 5 mm depth or to the applicator surface according to the distance between the applicator and the rectum. In vivo dosimetry measured the dose of the rectum and/or urinary bladder. With a high measured dose, the dose prescription was changed from a 5 mm depth to the applicator surface. (3) Results: The median age was 66 years with 58.8 months mean follow-up. The dose prescription was changed in 20.7% of group A and in 41% of group B. Most toxicities were grade 1–2. Acute urinary toxicities were significantly higher in group A. The rates of acute and late urinary toxicities were significantly higher with a mean bladder dose/fraction of >2.5 Gy and a total bladder dose of >7.5 Gy. One patient had a vaginal recurrence. (4) Conclusions: Both schedules have excellent local control and acceptable rates of toxicities. Using in vivo dosimetry-based biological planning yielded an acceptable dose to the bladder and rectum.
format article
author Tamer Soror
Ramin Chafii
Valentina Lancellotta
Luca Tagliaferri
György Kovács
author_facet Tamer Soror
Ramin Chafii
Valentina Lancellotta
Luca Tagliaferri
György Kovács
author_sort Tamer Soror
title Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy)
title_short Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy)
title_full Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy)
title_fullStr Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy)
title_full_unstemmed Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy)
title_sort biological planning of radiation dose based on in vivo dosimetry for postoperative vaginal-cuff hdr interventional radiotherapy (brachytherapy)
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/72b51afaad9743568ded63bddfb66880
work_keys_str_mv AT tamersoror biologicalplanningofradiationdosebasedoninvivodosimetryforpostoperativevaginalcuffhdrinterventionalradiotherapybrachytherapy
AT raminchafii biologicalplanningofradiationdosebasedoninvivodosimetryforpostoperativevaginalcuffhdrinterventionalradiotherapybrachytherapy
AT valentinalancellotta biologicalplanningofradiationdosebasedoninvivodosimetryforpostoperativevaginalcuffhdrinterventionalradiotherapybrachytherapy
AT lucatagliaferri biologicalplanningofradiationdosebasedoninvivodosimetryforpostoperativevaginalcuffhdrinterventionalradiotherapybrachytherapy
AT gyorgykovacs biologicalplanningofradiationdosebasedoninvivodosimetryforpostoperativevaginalcuffhdrinterventionalradiotherapybrachytherapy
_version_ 1718412903729594368